Stock A012790 SINIL PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sinil Pharmaceutical Co., Ltd.

Equities

A012790

KR7012790002

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-02 EDT 		5-day change 1st Jan Change
7,040 KRW 0.00% Intraday chart for Sinil Pharmaceutical Co., Ltd. +1.00% -8.69%
2023 Sinil Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Sinil Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 72,723 75,125 247,300 128,314 96,840 87,711
Enterprise Value (EV) 1 59,042 62,058 233,099 107,717 73,626 64,836
P/E ratio 12.7 x 10.4 x 32.3 x 18.9 x 7.78 x 6.53 x
Yield - - - - - -
Capitalization / Revenue 1.37 x 1.24 x 4.03 x 2.08 x 1.21 x 0.98 x
EV / Revenue 1.11 x 1.02 x 3.79 x 1.74 x 0.92 x 0.73 x
EV / EBITDA 6.2 x 4.53 x 21.1 x 8.6 x 4.07 x 3.35 x
EV / FCF -98.8 x 608 x -109 x 13.2 x 495 x -22.7 x
FCF Yield -1.01% 0.16% -0.91% 7.56% 0.2% -4.41%
Price to Book 0.76 x 0.53 x 2.27 x 1.12 x 0.77 x 0.66 x
Nbr of stocks (in thousands) 11,593 11,593 11,418 11,406 11,393 11,376
Reference price 2 6,273 6,480 21,658 11,250 8,500 7,710
Announcement Date 19-03-01 20-02-29 21-03-01 22-03-01 23-03-01 24-02-29
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 53,277 60,648 61,438 61,754 80,007 89,135
EBITDA 1 9,530 13,697 11,053 12,518 18,088 19,353
EBIT 1 5,851 9,415 6,621 7,982 13,656 13,991
Operating Margin 10.98% 15.52% 10.78% 12.93% 17.07% 15.7%
Earnings before Tax (EBT) 1 5,779 8,345 8,162 8,341 14,645 14,953
Net income 1 5,714 7,257 7,544 6,679 12,157 13,641
Net margin 10.72% 11.97% 12.28% 10.82% 15.2% 15.3%
EPS 2 492.9 626.0 670.3 594.1 1,093 1,180
Free Cash Flow 1 -597.5 102.1 -2,130 8,141 148.7 -2,857
FCF margin -1.12% 0.17% -3.47% 13.18% 0.19% -3.2%
FCF Conversion (EBITDA) - 0.75% - 65.03% 0.82% -
FCF Conversion (Net income) - 1.41% - 121.89% 1.22% -
Dividend per Share - - - - - -
Announcement Date 19-03-01 20-02-29 21-03-01 22-03-01 23-03-01 24-02-29
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 13,682 13,068 14,200 20,597 23,214 22,875
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -598 102 -2,130 8,141 149 -2,857
ROE (net income / shareholders' equity) 6.14% 7.39% 7.23% 6.05% 10.3% 10.6%
ROA (Net income/ Total Assets) 3.5% 5.25% 3.41% 3.93% 6.28% 5.92%
Assets 1 163,211 138,280 221,179 169,884 193,572 230,327
Book Value Per Share 2 8,211 12,227 9,551 10,069 11,082 11,677
Cash Flow per Share 2 149.0 359.0 370.0 653.0 444.0 651.0
Capex 1 8,335 9,730 8,801 3,343 10,351 13,604
Capex / Sales 15.64% 16.04% 14.33% 5.41% 12.94% 15.26%
Announcement Date 19-03-01 20-02-29 21-03-01 22-03-01 23-03-01 24-02-29
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
SINIL PHARMACEUTICAL CO., LTD. Stock Sinil Pharmaceutical Co., Ltd.
-8.69% 59.12M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.98% 43.48B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.67% 22.65B
SANDOZ GROUP AG Stock Sandoz Group AG
+14.56% 14.73B
CIPLA LIMITED Stock Cipla Limited
+14.32% 13.79B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+44.72% 12.04B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.37% 7.08B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+11.90% 5.47B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A012790 Stock
  4. Financials Sinil Pharmaceutical Co., Ltd.